GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (NAS:XOMAP.PFD) » Definitions » Ending Cash Position

XOMAP.PFD (XOMA Royalty) Ending Cash Position : $95.03 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is XOMA Royalty Ending Cash Position?

XOMA Royalty's Ending Cash Position for the quarter that ended in Mar. 2025 was $95.03 Mil.

XOMA Royalty's quarterly Ending Cash Position declined from Sep. 2024 ($146.82 Mil) to Dec. 2024 ($106.42 Mil) and declined from Dec. 2024 ($106.42 Mil) to Mar. 2025 ($95.03 Mil).

XOMA Royalty's annual Ending Cash Position increased from Dec. 2022 ($57.83 Mil) to Dec. 2023 ($159.55 Mil) but then declined from Dec. 2023 ($159.55 Mil) to Dec. 2024 ($106.42 Mil).

XOMA Royalty Ending Cash Position Historical Data

The historical data trend for XOMA Royalty's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty Ending Cash Position Chart

XOMA Royalty Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.36 95.38 57.83 159.55 106.42

XOMA Royalty Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 142.40 149.92 146.82 106.42 95.03

XOMA Royalty Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

XOMA Royalty's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=159.55+-53.134
=106.42

XOMA Royalty's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=106.416+-11.389
=95.03

XOMA Royalty Ending Cash Position Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA Royalty Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (NAS:XOMAP.PFD) » Definitions » Ending Cash Position
Comparable Companies
PRTA HUMA HRTX ABSI TERN NKTR PRME CYDY OLMA ATXS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
XOMAO.PFD:USA XOMA:USA 0M26:UK
Address
2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
Website
https://www.xoma.com
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.